Published July 2, 2021 | Version v1
Journal article Open

Antibody Characterization Report for Superoxide dismutase [Cu-Zn] (SOD1)


Head to head comparison of available commercial antibodies against Superoxide dismutase [Cu-Zn] (SOD1) by immunoblot (Western blot), immunoprecipitation and immunofluorescence. The workflow and data collected in this study was used to create an article published on F1000, DOI: 10.12688/f1000research.132952.2.

This work is part of the ALS-Reproducible Antibody Platform (ALS-RAP). ALS-RAP was created as a public-private partnership by three leading ALS charities - the ALS Association (USA), the Motor Neurone Disease Association (UK), and the ALS Society of Canada.


Superoxide dismutase [Cu-Zn]_SOD1-YCharOS report.pdf

Files (2.5 MB)